Mangrove Partners’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-500,000
Closed -$4.93M 628
2022
Q1
$4.93M Buy
+500,000
New +$4.93M 0.27% 105
2021
Q4
Sell
-300,000
Closed -$2.92M 597
2021
Q3
$2.92M Hold
300,000
0.26% 113
2021
Q2
$2.9M Hold
300,000
0.3% 90
2021
Q1
$2.92M Buy
+300,000
New +$2.92M 0.29% 89